Old Web
English
Sign In
Acemap
>
authorDetail
>
Silvina Gallo
Silvina Gallo
Merck & Co.
Ertugliflozin
Diabetes mellitus
Internal medicine
Placebo
Cardiology
4
Papers
60
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1232-P: Predictors of ß-Cell Function Changes: Pooled Analysis from Phase 3 Ertugliflozin Studies
2019
Diabetes
Silvina Gallo
Annaswamy Raji
Roberto A. Calle
Misoo C. Ellison
Christian Meyer
Show All
Source
Cite
Save
Citations (0)
Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy—104-Week VERTIS MET Trial
2018
Diabetes
Silvina Gallo
B. Charbonnel
Allison Goldman
Harry Shi
Susan Huyck
Amanda Darekar
Brett Lauring
Steven G. Terra
Show All
Source
Cite
Save
Citations (0)
EFFECTS OF ERTUGLIFLOZIN ON BLOOD PRESSURE AND PULSE RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
2018
Journal of the American College of Cardiology
Jie Liu
Annpey Pong
Silvina Gallo
Amanda Darekar
Steven Terra
Brett Lauring
Show All
Source
Cite
Save
Citations (0)
DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV)
2018
Journal of the American College of Cardiology
Christopher P. Cannon
Darren K. McGuire
Richard E. Pratley
Samuel Dagogo-Jack
James P. Mancuso
Susan Huyck
Bernard Charbonnel
Weichung Shih
Silvina Gallo
Urszula Masiukiewicz
Gregory T. Golm
Cosentino Francesco
Brett Lauring
Steven G. Terra
Show All
Source
Cite
Save
Citations (60)
1